The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 13, 2011, Pages

  Rubinstein, Ethan ^a,e   Predy, Gerald ^b,e   Sauvé, Laura ^c,e   Hammond, Greg W ^a,e   Aoki, Fred ^a,e   Sikora, Chris ^b,e   Li, Yan ^d,e   Law, Barbara ^e   Halperin, Scott ^e,f   Scheifele, David ^c,e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ABORIGINAL CANADIAN; ABORIGINE; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FATIGUE; FEMALE; HEALTH CARE UTILIZATION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; OUTCOME ASSESSMENT; PATIENT MONITORING; SINGLE DRUG DOSE;

EID: 80053084107     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.110196     Document Type: Article

References (15)

1. Zarychanski R, Stuart T, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010;182:257-64.
2. Kumar A, Zarychanski R, Pinto R, et al. for the Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-9.
3. Frequently asked questions - H1N1 flu virus. H1N1 in Aboriginal, First Nation and Inuit communities. Ottawa (ON): Public Health Agency of Canada; 2009. Available: www.phac-aspc.gc.ca /alert-alerte/h1n1/faq/faq-rg-h1n1-anic-eng.php. (accessed 2011 Jan. 20).
4. Deaths related to the 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives - 12 states, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1341-4.
5. A-adjuvanted influenza A (H1N1) vaccine for adults up to 85 years of age. Clin Infect Dis 2010;51:668-77.
6. Langley JM, Frenette L, Ferguson L, et al. Safety and cross-reactive immunogenicity of candidate ASO3-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. J Infect Dis 2010;201:1644-53.
7. Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009;459:1122-5.
8. Pandemic (H1N1) 2009 influenza update: Results from second clinical trial of GSK's H1N1 adjuvanted vaccine confirm immune response and tolerability [press release]. London (UK): GlaxoSmithKline; 2009. Available: www.gsk.com/media /pressreleases/2009/2009-pressrelease-10111.htm (accessed 2009 Oct. 21).
9. Committee for Proprietary Medicinal Products (CHMP). Note for guidance on harmonization of the requirements for influenza vaccine. London (UK): The European Agency for the Evaluation of Medicinal Products; 1997. Available: www .ema .europa.eu /pdfs/human/bwp/021496en.pdf (accessed 2011 June 9).
10. Statement on influenza vaccination for the 2008-2009 season: an Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:(ACS-3): 1-46.
11. Scheifele DW, Dionne M, De Serres G, et al. PCIRN study of adults given monovalent, adjuvated H1N1 vaccine with concurrent or delayed trivalent seasonal influenza vaccination. Canadian Immunization Conference, Quebec City, December 3-5, 2010 (abstract P141). Can J Infect Dis Med Microbiol 2010; 21: 226.
12. Hobson D, Curry RL, Beare AS, et al. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972;70:767-77.
13. Minuk GY, Uhanova J. Viral hepatitis in the Canadian Inuit and First Nations populations. Can J Gastroenterol 2003;17: 707-12. (Pubitemid 38072334)
14. Rempel JD, Aborsangaya KB, Alphonse MP, et al. The influence of North American Aboriginal ethnicity on pro -inflammatory and anti-inflammatory cytokine responses to IFN-alpha. J Viral Hepat 2009;16:292-7.
15. Mayet A, Ligier C, Gache K, et al. Adverse events following pandemic influenza vaccine Pandemrix reported in the French military forces - 2009-2010. Vaccine 2011;29:2576-81.